3557 results for «240»
3557 results
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from ICBA Instituto Cardiovascular de Buenos Aires to explore the Myval balloon-expandable transcatheter heart valve platform. Gain expert insights into imaging strategies, valve sizing, and procedural decision-making through a live case demonstration. The session also offers practical tips and technical pearls...
Management of aortic stenosis: what really matters before and after the procedure
11 Sep 2025 – From PCR Rio Valves 2025
Dive into the comprehensive management of aortic stenosis, focusing on critical decision-making before and after intervention. This session discusses surgical versus transcatheter treatment options, real-world application in asymptomatic patients, and strategies for long-term management including repeat valve interventions.
Innovation session: new techniques and devices in Latin America
11 Sep 2025 – From PCR Rio Valves 2025
Join this innovation-focused session highlighting new structural heart devices and techniques emerging from Latin America. Review real-world cases including mechanical valve re-intervention, TMVR, novel mitral TEER devices, and first clinical experiences with a new self-expandable transcatheter aortic valve in small annuli. Gain valuable procedural and clinical...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
The role of mitral TEER in advanced heart failure
11 Sep 2025 – From PCR Rio Valves 2025
This session delves into the role of mitral transcatheter edge-to-edge repair (TEER) in advanced heart failure patients. Understand the indications for mitral TEER in severe left ventricular dysfunction, prognostic challenges in heart failure with severe mitral regurgitation, and review therapeutic alternatives including the pathway from TEER...
How to optimise outcome in valve-in-valve and valve-in-mitral annular calcification patients
12 Sep 2025 – From PCR Rio Valves 2025
This session provides valuable insights into optimizing outcomes in valve-in-valve and valve-in-mitral annular calcification interventions. Learn from clinical evidence and detailed case presentations focusing on procedural steps and strategies to mitigate risks such as left ventricular outflow tract obstruction in high-risk patients.
Management of hostile access for TAVI
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses the management of hostile access routes for TAVI, focusing on identifying difficult access via pre-procedural CT, mastering techniques to overcome these challenges, and managing peri- and post-operative complications. Case presentations include challenging femoral access using shockwave balloon, carotid access, and transcaval approaches.
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Redo TAVI
12 Sep 2025 – From PCR Rio Valves 2025
Gain essential knowledge on planning and executing redo TAVI procedures. This session covers key characteristics of different transcatheter aortic valves, individual procedural strategies, and prevention of complications such as coronary obstruction in valve-in-valve scenarios through detailed case discussions.
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
04 Nov 2024
Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.
Also watch the interview with Susheel K. Kodali
Author
Best of #AHA20 Interventional Trials
19 Nov 2020
Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.
Author
